Scientists show how gene variant linked to ADHD could operate

August 16, 2011 in Attention deficit disorders

A study using mice provides insight into how a specific receptor subtype in the brain could play a role in increasing a person's risk for attention-deficit hyperactivity disorder (ADHD). The research, conducted by the Intramural Research Program (IRP) at the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health, could also help explain how stimulants work to treat symptoms of ADHD.

Dysfunction of the dopamine D4 receptor subtype is linked to ADHD as well as other disorders characterized by decreased , including drug abuse. One subtype variant, D4.7, has been of particular interest because of its increased prevalence in those diagnosed with ADHD. However, the function of this particular variant in ADHD has been poorly understood.

In the study, published in today's , researchers inserted three variants of the dopamine D4 receptor into cells and into mice so that they could investigate differences in biological activities. The researchers found that the D4.7 variant, unlike its D4.2 and D4.4 counterparts, was not able to interact with the short version of the dopamine type 2 (D2S) receptor to reduce glutamate release in a brain region associated with and symptoms of ADHD in humans.

"Although previous studies have shown that dysfunctional D4 receptors are implicated in ADHD, this is the first study to show how this might translate into seen with this disorder," said NIDA Director Dr. Nora D. Volkow. "Further research is needed to explore how this deficient interaction between receptors might be remedied, which could then lead to new medications for the treatment of ADHD."

Children with ADHD have trouble paying attention and controlling impulsive behaviors, and may be overly active, often resulting in poor school performance and . They are also at increased risk for substance use disorders, particularly if their symptoms go untreated.

ADHD is the most commonly diagnosed neurobehavioral disorder of childhood, and the number of children diagnosed continues to rise. According to the Center for Disease Control's National Survey of Children's Health, the number of children aged 4-17 years that were identified by their parent as ever being diagnosed with ADHD increased by 21.8 percent from 2003-2007. By 2007, nearly one in 10 children aged 4-17 years were, at some point, diagnosed with ADHD. Among children with current ADHD diagnoses, 66.3 percent were taking medication for the disorder.

The most commonly used treatment for ADHD involves administering psychostimulant medications. Although these medications alleviate some of the symptoms of ADHD, it is unclear how these compounds act within the brain to do so.

"Our results suggest that psychostimulants might reduce glutamate release by amplifying this D4/D2S interaction," said Dr. Sergi Ferre, primary author for the study. "These results might also explain why these medications are less efficient in patients with the D4.7 variant."

Provided by National Institutes of Health

5 /5 (1 vote)  

Rank 5 /5 (1 vote)
Related Stories
Relevant PhysicsForums posts
  • Magnetic field and repulsion bewteen wires
    created2 hours ago
  • Enthalpy of reaction
    created8 hours ago
  • Harmonic oscillation problem -Dancing pot
    created9 hours ago
  • Ultracapacitor to power electromagnet?
    created10 hours ago
  • Confusion in Electro Statics
    created10 hours ago
  • simple gravity question
    created11 hours ago
  • More from Physics Forums - Classical Physics

More news stories

First long-term study reveals link between childhood ADHD and obesity

A new study conducted by researchers at the Child Study Center at NYU Langone Medical Center found men diagnosed as children with attention-deficit/hyperactivity disorder (ADHD) were twice as likely to be obese in a 33-year ...

Attention deficit disorders created 6 hours ago | popularity not rated yet | comments 0 | with audio podcast

Expert explores how sunlight may affect ADHD patients

Researchers are interested in exploring how sunlight, sleep and screens (like those on computers and TVs) may affect those with attention-deficit/hyperactivity disorder (ADHD), says Dr. L. Eugene Arnold, a child psychiatrist ...

Attention deficit disorders created May 17, 2013 | popularity 5 / 5 (3) | comments 0

Long-term ADHD treatment increases brain dopamine transporter levels, may affect drug efficacy

Long-term treatment of attention deficit/hyperactivity disorder (ADHD) with certain stimulant medications may alter the density of the dopamine transporter, according to research published May 15 in the open access journal ...

Attention deficit disorders created May 15, 2013 | popularity not rated yet | comments 0

Can breastfeeding protect against ADHD?

Breastfeeding has a positive impact on the physical and mental development of infants. A new study suggests that breastfeeding may protect against the development of attention-deficit/hyperactivity disorder ...

Attention deficit disorders created May 14, 2013 | popularity not rated yet | comments 0

Methylphenidate 'normalizes' activation in key brain areas in kids with ADHD

The stimulant drug methylphenidate "normalizes" activation of several brain areas in young patients with attention-deficit/hyperactivity disorder (ADHD), according to a review published in the May Harvard Review of Psychiatry. ...

Attention deficit disorders created May 09, 2013 | popularity 5 / 5 (2) | comments 0


Researchers develop model for better testing, targeting of malignant peripheral nerve sheath tumors

University of Minnesota Medical School researchers from the Masonic Cancer Center, University of Minnesota, in partnership with the University's Brain Tumor Program, have developed a new mouse model of malignant peripheral ...

Practice makes perfect? Not so much

Turns out, that old "practice makes perfect" adage may be overblown. New research led by Michigan State University's Zach Hambrick finds that a copious amount of practice is not enough to explain why people ...

Older prostate cancer patients should think twice before undergoing treatment

Older prostate cancer patients with other underlying health conditions should think twice before committing to surgery or radiation therapy for their cancer, according to a multicenter study led by researchers in the UCLA ...

New test better detects elephantiasis worm infection

A new diagnostic test for a worm infection that can lead to severe enlargement and deformities of the legs and genitals is far more sensitive than the currently used test, according to results of a field ...

Leading researchers report on the elusive search for biomarkers in Huntington's disease

While Huntington's disease (HD) is currently incurable, the HD research community anticipates that new disease-modifying therapies in development may slow or minimize disease progression. The success of HD research depends ...

Vermont becomes third US state to legalize assisted suicide

Vermont became on Monday the third US state to legalize physician-assisted suicide.